biotechnology

The chief medical officer of BioNTech told CNBC that people will likely need a third shot of its two-dose Covid-19 vaccine as immunity against the virus wanes.

The FDA said a Baltimore plant that ruined millions of Johnson & Johnson Covid-19 vaccine doses was unsanitary and unsuitable to manufacture the shots.

J&J’s financial results come as the company’s Covid-19 vaccine has been put on pause in the United States.

Dr. Carlos Del Rio explains what the U.S. needs to do in order to see Covid cases dramatically drop in May.

U.S. officials have confirmed fewer than 6,000 cases of Covid-19 in fully vaccinated Americans, just 0.007% of the 84 million Americans with full protection.

“It’s almost paradoxical that they don’t want to get vaccinated,” White House chief medical advisor Dr. Anthony Fauci said.

Emergent said the FDA initiated an inspection on April 12 and asked the company to temporarily halt manufacturing four days later.

Americans do not “seem to be prepared” to do what’s necessary to stamp out Covid, former FDA chief Dr. Scott Gottlieb told CNBC.

J&J asked Covid vaccine rivals Pfizer and Moderna to join a study looking into the potential risk of blood clots, The Wall Street Journal reported.

The Biden administration is preparing for the potential need for Covid-19 vaccine booster shots, though nothing is certain, a top U.S. official said.

CDC Director Dr. Rochelle Walensky said earlier this month hospitals are seeing more younger adults admitted with Covid-19 as more contagious variants spread.

Some experts say it is achievable, though difficult — but others are warning that herd immunity may not be possible when it comes to COVID-19.

Merck announced Thursday it will end the development of its experimental drug for patients hospitalized with severe Covid-19.

Dr. Atul Gawande explains why he “thinks there is something distinct going on here” when it comes to blood clotting and J&J’s single-dose Covid-19 vaccine.

A CDC panel on Wednesday postponed a decision on J&J’s Covid vaccine while it investigates cases of six women developing a rare blood-clotting disorder.

Moderna CEO Stephane Bancel told CNBC the biotech firm hopes to have a booster shot for its Covid vaccine to protect against variants ready by the fall.

The Advisory Committee on Immunization Practices will review data on the women who developed a rare blood-clotting disorder.

Jeff Zients said the FDA’s recommended pause on J&J’s vaccine would not have a “significant impact” on the administration’s vaccination program.

Dr. Fauci said the pause will give U.S. health regulators the time they need to thoroughly investigate how six women developed a rare blood clotting disorder.

Dr. Ashish Jha explains the impact of temporarily pausing use of the J&J Covid vaccine, and why he thinks it may bolster confidence in Covid vaccines.